University of Colorado Anschutz Medical Campus

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study (2025) Rangelova E, Stoop TF, van Ramshorst TM, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, et al. Journal article Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer (2024) Nelson BH, Hamilton P, Phung MT, Milne K, Harris B, Thornton S, Stevens D, et al. Journal article Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making (2024) Hsia J, Shivappa N, Bakhai A, Bover J, Butler J, Ferraro PM, Fried L, et al. Journal article Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma (2024) Saner FA, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, et al. Journal article VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases (2024) Neurath M, Berg LJ Journal article, Review article MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature (2024) Karayol R, Borroto MC, Haghshenas S, Namasivayam A, Reilly J, Levy MA, Relator R, et al. Journal article Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis (2024) Hollenbach M, Heise C, Abou-Ali E, Gulla A, Auriemma F, Soares K, Leung G, et al. Journal article Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders (2024) Mougiakakos D, Sengupta R, Gold R, Schroers R, Haghikia A, Lorente M, Pendleton M, et al. Journal article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease (2024) Deane KD, Michael Holers V, Emery P, Mankia K, El Gabalawy H, Sparks JA, Costenbader KH, et al. Journal article, Review article